Ensign Peak Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-102,726
| Closed | -$15.5M | – | 2348 |
|
|
2022
Q3 | $15.5M | Hold |
102,726
| – | – | 0.04% | 301 |
|
|
2022
Q2 | $15M | Sell |
102,726
-34,014
| -25% | -$4.96M | 0.04% | 311 |
|
|
2022
Q1 | $16.2M | Buy |
136,740
+14,327
| +12% | +$1.7M | 0.03% | 329 |
|
|
2021
Q4 | $16.9M | Buy |
122,413
+28,921
| +31% | +$3.99M | 0.03% | 354 |
|
|
2021
Q3 | $13M | Buy |
93,492
+14,031
| +18% | +$1.95M | 0.03% | 384 |
|
|
2021
Q2 | $7.71M | Buy |
79,461
+13,653
| +21% | +$1.33M | 0.02% | 502 |
|
|
2021
Q1 | $4.5M | Buy |
65,808
+29,522
| +81% | +$2.02M | 0.01% | 675 |
|
|
2020
Q4 | $3.11M | Hold |
36,286
| – | – | 0.01% | 815 |
|
|
2020
Q3 | $2.36M | Sell |
36,286
-28,256
| -44% | -$1.84M | 0.01% | 874 |
|
|
2020
Q2 | $4.72M | Buy |
64,542
+18,469
| +40% | +$1.35M | 0.01% | 621 |
|
|
2020
Q1 | $1.57M | Buy |
46,073
+20,647
| +81% | +$703K | 0.01% | 952 |
|
|
2019
Q4 | $1.38M | Buy |
+25,426
| New | +$1.38M | ﹤0.01% | 1212 |
|